Scientific News: Penumbra stock jumps. It’s being bought by Boston Scientific for $14.5 billion

Choose a language:

Science Daily Reports

Details: Written by Bing News Search Results; Category: Science Daily Reports; Published: 15 January 2026; Created: 15 January 2026; Last Updated: 15 January 2026

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst performers in the S&P 500. Boston Scientific was a Barron’s stock pick in October.
Original Image Link
Source:www.msn.com

Posted: 2026-01-15 08:16:00

Get Full News Story On Bing Science News Network

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

More News From This Category
Scientific News: Boston Scientific inks $14.5B deal, boosting its Minnesota-dominated heart device portfolio
Thu, 15 Jan 2026 17:07:17 +0000

Boston Scientific has long used mergers and acquisitions to fuel growth. This deal appears to be its largest since its acquisition of Arden Hills pacemaker company Guidant in 2006 for $27B.
Original Image Link
Source:www.startribune.com

Scientific News: Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to fast-growing vascular segments
Thu, 15 Jan 2026 17:07:17 +0000

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as blood ...
Original Image Link
Source:www.msn.com

Scientific News: Penumbra stock jumps. It’s being bought by Boston Scientific for $14.5 billion
Thu, 15 Jan 2026 14:07:15 +0000

Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, which makes mechanical thrombectomy products for vascular procedures, expands ...
Original Image Link
Source:www.msn.com

Scientific News: Boston Scientific to buy Penumbra for more than $14 billion
Thu, 15 Jan 2026 14:07:15 +0000

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots from veins and arteries.
Original Image Link
Source:www.bostonglobe.com

Related Bing News Results